News
CTXR
--
0.00%
--
Thinking about buying stock in Welbilt, Ocugen, Obseva, Ericsson, or Citius Pharmaceuticals?
NEW YORK, April 21, 2021 /PRNewswire via COMTEX/ -- NEW YORK, April 21, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WBT,...
PR Newswire - PRF · 5h ago
Citius Thrives in 2021 with Critical Care Solutions for ARDS Associated with COVID-19
The following article is sponsored by Citius Pharmaceuticals, Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only.
Benzinga · 2d ago
3 Penny Stocks To Watch Trading Higher In 2021 Consolidating In April
Apr 10, 2021 (Penny Stocks via COMTEX) -- Can These Biotech Penny Stocks Rebound In Q2 The phrase "penny stocks" refers to shares of companies trading under...
Penny Stocks · 04/10 15:38
Exclusive: Citius Pharmaceuticals Exec Chairman On Product Pipeline, Potential $1B TAM
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Executive Chairman Leonard Mazur told Benzinga CEO Jason Raznick Thursday that he's invested $26.5 million of his own money in the specialty pharmaceutical company. 
Benzinga · 04/08 21:25
BRIEF-Citius Pharmaceuticals Inc Files For Mixed Shelf Of Upto $250 Million
reuters.com · 04/02 22:22
Best Penny Stocks To Buy Right Now? 4 For Your March List
Mar 24, 2021 (Penny Stocks via COMTEX) -- Are These 4 Penny Stocks On Your Watch List Right Now? On Tuesday, March 23rd, both penny stocks and blue chips...
Penny Stocks · 03/24 19:27
Citius Pharmaceuticals to Highlight its Phase 3 Clinical Trial Product Mino-Lok® at Benzinga Biotech Small Cap Conference on March 25
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, will participate in the virtual Benzinga Biotech Small Cap Conference being held March 2...
PR Newswire · 03/23 14:00
Citius Pharmaceuticals To Highlight Its Phase 3 Clinical Trial Product Mino-Lok At Benzinga Biotech Small Cap Conference On March 25
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ:CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, will participate in the virtual
Benzinga · 03/23 13:04
Real Chemistry and the Media Empathy Foundation Partner at SXSW, Launching "Culture Care" to Reduce Disease-Related Stigma and Bias Through Data-Driven Creative Content
Global health innovation company Real Chemistry announced today at the 2021 SXSW Healthcare Media Lounge that it is partnering with the non-profit Media Empathy Foundation to deliver "Culture Care" engagement and education campaigns that will help reduce s...
BusinessWire · 03/18 20:15
Top Penny Stocks to Watch Before The End Of The Week
Mar 17, 2021 (Penny Stocks via COMTEX) -- Will These 5 Penny Stocks Continue Climbing This Week? While March continues to be bullish for many penny stocks,...
Penny Stocks · 03/18 00:06
Thinking about buying stock in Cardiff Oncology, Nio, Intuit, Accenture, or Citius Pharmaceuticals?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CRDF, NIO, INTU, ACN, and CTXR.
PR Newswire - PRF · 03/15 12:30
Thinking about buying stock in Nio, Norwegian Cruise Line, Immunovant, Devon Energy, or Citius Pharmaceuticals?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIO, NCLH, IMVT, DVN, and CTXR.
PR Newswire - PRF · 03/08 15:55
Hot Reddit Penny Stocks For Your Watch List In March 2021
Mar 05, 2021 (Penny Stocks via COMTEX) -- Reddit Penny Stocks Continue Surging But Are They Worth The Risk? The stock market continues selling off today and...
Penny Stocks · 03/05 17:40
Citius Pharmaceuticals to Feature Product Candidates Including Stem-Cell Therapy for COVID-19-Related Acute Respiratory Conditions at H.C. Wainwright Global Life Sciences Conference March 9-10
, /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, today announced that it will present at the H.C. Wainwright Global Li...
PR Newswire - PRF · 03/04 15:38
H.C. Wainwright Reiterates a Buy Rating on Citius Pharmaceuticals (CTXR)
In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Citius Pharmaceuticals (CTXR), with a price target of $4.00.
SmarterAnalyst · 03/01 11:26
Thinking about buying stock in BlackBerry, Express, Norwegian Cruise Line, Citius Pharmaceuticals, or Verizon?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BB, EXPR, NCLH, CTXR, and VZ.
PR Newswire - PRF · 02/25 15:45
Dawson James Sticks to Its Buy Rating for Citius Pharmaceuticals (CTXR)
SmarterAnalyst · 02/25 09:07
3 Penny Stocks For Your Watch List This Week If Biotech Is A Focus
Feb 24, 2021 (Penny Stocks via COMTEX) -- Biotech Penny Stocks To Watch Right Now If one grouping of penny stocks that've gained attention in the markets, it...
Penny Stocks · 02/24 21:12
4 Cheap Penny Stocks To Buy For Under $5 Before March 2021
Feb 24, 2021 (Penny Stocks via COMTEX) -- Are These Cheap Penny Stocks On Your "Buy" List Today? When someone says the words "penny stocks," what comes to...
Penny Stocks · 02/24 21:12
Thinking about buying stock in Workhorse Group, Globalstar, Palantir Technologies, Marathon Oil, or Citius Pharmaceuticals?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WKHS, GSAT, PLTR, MRO, and CTXR.
PR Newswire - PRF · 02/24 16:30
Webull provides a variety of real-time CTXR stock news. You can receive the latest news about Citius Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About CTXR
Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is focused on developing and commercializing care products with a focus on anti-infective products in adjunct cancer care and prescription products. It has three product candidates: Mino-Lok, CITI-002 (halobetasol-lidocaine formulation) and CITI-101 (Mino-Wrap). Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections (CRBSIs). Mino-Lok product is designed to salvage the central venous catheters CVC, obviating the need to remove and replace the catheter. Mino-Wrap is a bio-absorbable film impregnated with minocycline and rifampin for reducing acute inflammation and microbial colonization of breast tissue expanders used in breast reconstruction surgeries following mastectomies. CITI-002 is being developed for symptomatic relief of hemorrhoids. CITI-002 combines the steroid, halobetasol, with lidocaine.